Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism NAD+ modulators(NAD(Nicotinamide adenine dinucleotide) modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dry Eye Syndromes | Phase 2 | KR | 01 Oct 2012 | |
Xerophthalmia | Phase 2 | - | - |